Cresco Labs

Cresco Labs Opens Second Pensacola Florida Dispensary

Retrieved on: 
Monday, October 17, 2022
Tobacco, Hemp, Cannabis, Specialty, Alternative Medicine, Health, Retail, Agriculture, Natural Resources, Social equity, Medicine, Labs, Education, Volunteering, Walmart, Patient, No, Good news, Tropical Storm Ian, Multimedia, Knowledge, Nine Mile Road, SEED, Starbucks, CL, CSE, Cresco Labs, Water, Pensacola, Florida, CEO, Food, National Energy Education Development Project, Drug, Walgreens, Publix, Lorenzo Remedi

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (Cresco or the Company), a vertically integrated multistate operator and the No.

Key Points: 
  • Cresco Labs (CSE:CL) (OTCQX:CRLBF) (Cresco or the Company), a vertically integrated multistate operator and the No.
  • 1 U.S. wholesaler of branded cannabis products, today announced the expansion of its Sunnyside retail brand in Floridas Panhandle region with the opening of a second dispensary in Pensacola.
  • View the full release here: https://www.businesswire.com/news/home/20221013005280/en/
    Sunnyside Dispensary Announces Opening of Second Store in Pensacola Florida (Photo: Business Wire)
    Were excited to continue expanding access to Cresco Labs leading portfolio of products across Florida and to make a trip for medicine more convenient for Pensacolas patients, said Charlie Bachtell, co-Founder and CEO of Cresco Labs.
  • Sunnyside, Cresco Labs national dispensary brand, is a wellness-focused retailer created to build trust, education and convenience for both existing and new cannabis consumers.

Cresco Labs’ Bestselling Flagship Brand Cresco Launches in Florida

Retrieved on: 
Tuesday, September 20, 2022
Other Retail, Tobacco, Hemp, Cannabis, Specialty, Alternative Medicine, Health, Retail, Natural Resources, Risk, SEED, Social equity, Knowledge, Legislation, National Energy Education Development Project, Nature, Company, Labs, CL, Patient, No, CSE, Cresco Labs, Sunnyside, Florida, THCA, Private Securities Litigation Reform Act, Herbal cigarette, Good news, Multimedia, SEDAR, Education, Terpene, Glossary of cannabis terms, Drug, Fungiculture, Risk management, Lorenzo Remedi

1 U.S. wholesaler of branded cannabis products, announced today the expansion of its flagship brand, Cresco , to Florida.

Key Points: 
  • 1 U.S. wholesaler of branded cannabis products, announced today the expansion of its flagship brand, Cresco , to Florida.
  • View the full release here: https://www.businesswire.com/news/home/20220920005545/en/
    Cresco Labs flagship Cresco brand arrives at Sunnyside Florida stores with an expansive lineup of Liquid Live Resin vape (pictured) and Live Resin concentrates products.
  • The introduction of our Cresco brand, the most sold vape and concentrate brand in the United States, is an exciting addition to our robust Sunnyside Florida product assortment, said Greg Butler, Chief Commercial Officer at Cresco Labs.
  • Sunnyside, Cresco Labs national dispensary brand, is a wellness-focused retailer created to build trust, education and convenience for both existing and new cannabis consumers.

Cresco Labs Closes Sale-and-Leaseback with Aventine Property Group for Brookville, PA Facility

Retrieved on: 
Tuesday, September 6, 2022
Alternative Medicine, Cannabis, Retail, Health, Tobacco, Natural Resources, CSE, SEED, Cresco Labs, Labs, Aventine, Sale, Social equity, Education, Pennsylvania Office of Administration, Medical cannabis, LLC, Good news, CL, Knowledge, National Energy Education Development Project, Acquisition, Review, Drug, Lorenzo Remedi

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (Cresco or the Company), a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, today announced that it has completed and closed on an agreement to sell its Brookville, PA property to Aventine Property Group (Aventine) for total additional non-dilutive funding of $45 million.

Key Points: 
  • Cresco Labs (CSE:CL) (OTCQX:CRLBF) (Cresco or the Company), a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, today announced that it has completed and closed on an agreement to sell its Brookville, PA property to Aventine Property Group (Aventine) for total additional non-dilutive funding of $45 million.
  • This sale marks Cresco Labs first sale-leaseback transaction with Aventine.
  • Concurrent with the closing of the sale, Cresco Yeltrah, LLC, a subsidiary of Cresco Labs, entered into a long-term, triple-net lease agreement with Aventine regarding the property and Cresco Yeltrah will continue to operate the facility as the permitted cannabis cultivation and processing facility, as it has since 2017.
  • Cresco Labs CEO and Co-founder Charles Bachtell said, This transaction further strengthens our company, unlocking valuable capital from our balance sheet.

Cresco Labs Announces Three New Sunnyside Dispensaries in Florida

Retrieved on: 
Tuesday, August 30, 2022
Women, Tobacco, Cannabis, Men, Specialty, Alternative Medicine, Consumer, Health, Retail, Natural Resources, Patient, Best Buy, CEO, CSE, SEED, Cresco Labs, Labs, Entrepreneurship, Heart, Social equity, No, Veterans Parkway, Multimedia, Education, Publix, Good news, CL, Knowledge, National Energy Education Development Project, Drug, Lorenzo Remedi, Walmart

1 U.S. wholesaler of branded cannabis products, today announced the expansion of its Sunnyside retail brand in Florida with three new dispensaries in Cape Coral, Tampa and Panama City Beach, Florida.

Key Points: 
  • 1 U.S. wholesaler of branded cannabis products, today announced the expansion of its Sunnyside retail brand in Florida with three new dispensaries in Cape Coral, Tampa and Panama City Beach, Florida.
  • View the full release here: https://www.businesswire.com/news/home/20220830005370/en/
    Cresco Labs has opened three new Florida stores, bringing its Sunnyside network to 19 locations in the state and 53 total nationwide.
  • (Photo: Business Wire)
    We are thrilled to bring Cresco Labs portfolio of leading cannabis brands to patients in Cape Coral, Tampa and Panama City Beach, said Charlie Bachtell, Co-Founder and CEO of Cresco Labs.
  • Sunnyside, Cresco Labs national dispensary brand, is a wellness-focused retailer created to build trust, education and convenience for both existing and new cannabis consumers.

Cresco Labs Announces Second Quarter 2022 Results

Retrieved on: 
Wednesday, August 17, 2022
Natural Resources, Alternative Medicine, Health, Tobacco, Specialty, Food, Beverage, Cannabis, Retail, Misrepresentation, CEO, CL, Face, Eastern Time Zone, Knowledge, Education, Law of the United Kingdom, Cresco Labs, Student, SEDAR, FSE, Industry, Inventory, Technology, Central, Social justice, Environment, Tax, Nature, Webcast, CSE, Hand, Growth, LLC, Historical cost, Corona Labs Inc., Compliance, Entrepreneurship, Income, Mission statement, Acquisition, National Energy Education Development Project, Total, Organization, Social, Legislation, ICEC, Company, Depreciation, Social equity, GAAP, SEED, Private Securities Litigation Reform Act, Supreme court, Adult, Cresco, Drug, Video game, Real estate, Mobile phone, Online gambling, Retail, Bank, Audit, Adjustment

Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (Cresco Labs or the Company), a vertically integrated, multi-state operator and the no.

Key Points: 
  • Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (Cresco Labs or the Company), a vertically integrated, multi-state operator and the no.
  • 1 producer of branded cannabis products in the industry, today released its financial results for the quarter ended June 30, 2022.
  • On March 23, 2022, the Company announced a definitive arrangement agreement whereby Cresco Labs will acquire Columbia Care in an all-stock transaction.
  • The Company expects to file its unaudited interim condensed consolidated financial statements for the quarter ended June 30, 2022, on SEDAR by August 18, 2022.

Columbia Care Reports Second Quarter 2022 Results

Retrieved on: 
Monday, August 15, 2022
Other Manufacturing, Research, Manufacturing, Biotechnology, Alternative Medicine, General Health, Pharmaceutical, Health, Science, Other Science, Telephone, Disclosure, Seed, Internal Revenue Code, Risk, Investor relations, Industry, Forward-looking statement, Legislation, Amber, Jefferson Park, Indian stock exchange, Growth, Sale, YTD, THC, Internal Revenue Code section 409A, Adjustment, Disease, OH, Marketing, EBITDA, Review, Company, Mission statement, Secret (Classix Nouveaux album), Depreciation, Acquisition, 777, Oil, Form 10-Q, GAAP, Forecasting, SOP, Tablet, Net income, Goal, Cresco Labs, Adult, Cresco, Bank, Medical device, Online gambling, Tunnel, Fine chemical, Mobile phone, Bookkeeping, Risk management, Cannabist Kansai, Q2, EU

In addition, the Company expects sequential improvements in market level EBITDA margin in the range of 150-250 basis points per quarter compared to our YTD results.

Key Points: 
  • In addition, the Company expects sequential improvements in market level EBITDA margin in the range of 150-250 basis points per quarter compared to our YTD results.
  • At this time, Columbia Cares 2022 outlook does not assume any additional changes in the regulatory environment in markets where Columbia Care currently operates.
  • ET to discuss financial and operating results for the second quarter.
  • Columbia Care operates 131 facilities including 99 dispensaries and 32 cultivation and manufacturing facilities, including those under development.

Illinois Begins Issuing New Adult-Use Dispensary Licenses; Recipients Include Social Equity Groups Incubated by Cresco Labs’ SEED™ Initiative

Retrieved on: 
Monday, August 8, 2022
Retail, Specialty, Natural Resources, Cannabis, Good news, Running, CEO, CL, Growth, Timeline of cannabis laws in the United States, LLC, Knowledge, Community business, Social justice, Company, Education, Cannabis, Social equity, SEED, CSE, Illinois Cannabis Regulation and Tax Act, National Energy Education Development Project, Cresco Labs, Labs, Entrepreneurship, Drug, Lorenzo Remedi

Were thrilled for all new Illinois cannabis business owners who finally have the opportunity to get their businesses up and running.

Key Points: 
  • Were thrilled for all new Illinois cannabis business owners who finally have the opportunity to get their businesses up and running.
  • Were also incredibly proud of our Cresco Labs team members whothrough our SEED Community Business Incubatorassisted social equity groups with their license applications, said Charlie Bachtell, CEO and Co-Founder of Cresco Labs.
  • After a year and a half of delays, the state began issuing conditional adult-use dispensary licenses on July 22 to social equity applicants under the Cannabis Regulation and Tax Act.
  • SEEDs Community Business Incubator will continue to provide essential services and support to Parkway Dispensary, Navda Labs and all other social equity groups issued dispensary and craft grow licenses by the state.

Cresco Labs to Hold Second Quarter 2022 Earnings Conference Call on August 17, 2022

Retrieved on: 
Monday, August 1, 2022
Natural Resources, Alternative Medicine, Other Retail, Health, Tobacco, Hemp, Cannabis, Retail, National Energy Education Development Project, Knowledge, Education, CL, Cresco Labs, SEED, Webcast, Social equity, Company, Good news, CSE, Labs, Drug, Lorenzo Remedi

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (Cresco Labs or the Company), a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, today announced that it will report financial results for the second quarter ended June 30th, 2022, on Wednesday, August 17th, 2022, before the market opens.

Key Points: 
  • Cresco Labs (CSE:CL) (OTCQX:CRLBF) (Cresco Labs or the Company), a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, today announced that it will report financial results for the second quarter ended June 30th, 2022, on Wednesday, August 17th, 2022, before the market opens.
  • The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights.
  • Archived access to the webcast will be available for one year on the Cresco Labs investor relations website.
  • Cresco Labs is one of the largest vertically integrated multistate cannabis operators in the United States, with a mission to normalize and professionalize the cannabis industry.

Cresco Labs Announces Voting Results of Its Annual and Special Meeting of Shareholders

Retrieved on: 
Friday, July 15, 2022
Cannabis, Agriculture, Natural Resources, Health, Pharmaceutical, Meeting, Knowledge, Time, SEED, National Energy Education Development Project, Share, Social equity, Cresco Labs, NASDAQ, 2K resolution, Good news, Company, Investment, International investment agreement, New York Stock Exchange, Super, Education, Security (finance), Lorenzo Remedi

The final matter voted on at the Meeting relates to the Companys Super Voting Shares.

Key Points: 
  • The final matter voted on at the Meeting relates to the Companys Super Voting Shares.
  • At the Meeting, the shareholders approved the special resolution (the Special Resolution) to amend the articles of the Company such that following any future listing U.S.
  • Listing Event, no Super Voting Shares will remain outstanding and the Company will be unable to issue new Super Voting Shares.
  • Sunnyside, Cresco Labs national dispensary brand, is a wellness-focused retailer created to build trust, education and convenience for both existing and new cannabis consumers.

Columbia Care Obtains Final Order of the Supreme Court of British Columbia Approving Business Combination with Cresco Labs

Retrieved on: 
Friday, July 15, 2022
Supermarket, Retail, Natural Resources, Cannabis, 777, CEO, Amber, Seed, CSE, Cyprus Securities and Exchange Commission, Private Securities Litigation Reform Act, Risk, CL, Cannabis, NLRB v. Kentucky River Community Care, Inc., Supreme court, Cresco Labs, Legislation, SEDAR, Industry, Tablet, Company, Entrepreneurship, Oil, NEO, Law of the United Kingdom, FSE, Circular, Online gambling, EU, Arrangement, Cannabist Kansai

The final order follows on achieving overwhelming shareholder approval for the business combination at the special meeting of shareholders of the Company held on July 8, 2022.

Key Points: 
  • The final order follows on achieving overwhelming shareholder approval for the business combination at the special meeting of shareholders of the Company held on July 8, 2022.
  • This final order is yet another milestone achieved towards creating the industry leader in cannabis, and were pleased with the forward progress in completing the transformational combination with Cresco, said Nicholas Vita, Co-Founder, CEO of Columbia Care.
  • With this final order in hand, we are now focused on continued momentum in the divestiture process and state-level approvals.
  • As previously announced, in certain states namely Florida, Illinois, Maryland, Massachusetts, New York, and Ohio Columbia Care and Cresco Labs will divest assets for regulatory approval prior to close.